HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria

被引：0
|
作者：
Qi Sun
Qi Li
Fuping Gao
Hongyan Wu
Yao Fu
Jun Yang
Xiangshan Fan
Xiaobin Cui
Xiaohong Pu
机构：
[1] Nanjing Drum Tower Hospital,Department of Pathology
[2] The Affiliated Hospital of Nanjing University Medical School,Center for Digestive Medicine
[3] Nanjing Drum Tower Hospital,Department of Pathology
[4] The Affiliated Hospital of Nanjing University Medical School,undefined
[5] Gaochun People’s Hospital,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Colorectal carcinomas; HER2; Fluorescence in situ hybridization; Immunohistochemistry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：579 / 592
页数：13
相关论文
共 50 条
  • [31] Discrepancy Between HER2 Immunohistochemistry and Fluorescence In Situ Hybridization in Esophageal and Gastric Adenocarcinoma
    Huh, Won Jae
    Sanders, Melinda
    Charoenpitakchai, Mongkon
    Salaria, Sofia
    Washington, Mary
    Shi, Chanjuan
    MODERN PATHOLOGY, 2015, 28 : 165A - 166A
  • [32] Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer
    Stocker, Albina
    Trojan, Andreas
    Elfgen, Constanze
    Hilbers, Marie-Louis
    Moskovszky, Linda
    Varga, Zsuzsanna
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (02) : 311 - 319
  • [33] Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer
    Albina Stocker
    Andreas Trojan
    Constanze Elfgen
    Marie-Louis Hilbers
    Linda Moskovszky
    Zsuzsanna Varga
    Breast Cancer Research and Treatment, 2020, 183 : 311 - 319
  • [34] Automated Silver-enhanced In Situ Hybridization for Evaluation of HER2 Gene Status in Breast Carcinoma: Comparison with Fluorescence In Situ Hybridization and Immunohistochemistry
    Sung, Woo Jung
    Park, Seok Ju
    Gu, Mi Jin
    Bae, Young Kyung
    KOREAN JOURNAL OF PATHOLOGY, 2010, 44 (01) : 28 - 34
  • [35] Comparison between Fluorescence In Situ Hybridization (FISH) and Dual In Situ Hybridization (DISH) in the determination of HER2 status in breast cancer among Filipinos
    Espiritu, G. A.
    dela Fuente, E.
    Diwa, M.
    VIRCHOWS ARCHIV, 2019, 475 : S98 - S98
  • [36] HER2 Testing in 538 consecutive breast cancer cases using immunohistochemistry and fluorescence in situ hybridization
    Kovacs, A.
    Stenman, G.
    BREAST, 2007, 16 : S19 - S19
  • [37] Discordance between Immunohistochemistry (IHC) and In Situ Hybridization (ISH) to Detect HER2 Overexpression/Gene Amplification in Breast Cancer (BC) in the Modern Age
    Memon, Raima
    Prieto-Granada, Carlos
    Harada, Shuko
    Winokur, Thomas
    Reddy, Vishnu
    Siegal, Gene
    Wei, Shi
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 213 - 213
  • [38] Discordance between Immunohistochemistry (IHC) and In Situ Hybridization (ISH) to Detect HER2 Overexpression/Gene Amplification in Breast Cancer (BC) in the Modern Age
    Memon, Raima
    Prieto-Granada, Carlos
    Harada, Shuko
    Winokur, Thomas
    Reddy, Vishnu
    Siegal, Gene
    Wei, Shi
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 213 - 213
  • [39] - POINT - Fluorescence In Situ Hybridization Is the Preferred Approach over Immunohistochemistry for Determining HER2 Status
    Ross, Jeffrey S.
    CLINICAL CHEMISTRY, 2011, 57 (07) : 980 - 982
  • [40] Comparison of Immunohistochemistry and Fluorescence In Situ Hybridization for the Analysis of HER2/neu and Topoisomerase II-alpha Status in Human Breast Cancer
    Pala, Emel Ebru
    Zekioglu, Osman
    Ozdemir, Necmettin
    Yilmaz, Rasih
    Kapkac, Murat
    TURKISH JOURNAL OF PATHOLOGY, 2010, 26 (03) : 222 - 229
12345